Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BLM | P54132 | 2/20 | 0.63 |
| ▸ | ESR1 | P03372 | 9/20 | 0.61 |
| ▸ | ESR2 | Q92731 | 8/20 | 0.55 |
| ▸ | ABAT | P80404 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | TAAR1 | Q96RJ0 | 4/20 | 0.42 |
| ▸ | SLC6A2 | P23975 | 3/20 | 0.42 |
| ▸ | HTR2A | P28223 | 1/20 | 0.42 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.42 |
| ▸ | HRH1 | P35367 | 1/20 | 0.42 |
| ▸ | HTR2B | P41595 | 1/20 | 0.42 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.42 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | HTR1A | P08908 | 1/20 | 0.41 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | HTR3A | P46098 | 1/20 | 0.41 |
| ▸ | BACE1 | P56817 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25596195 | 1.00 | BLM (0.63) | BLMESR1ESR2ABATCA2 | |
| SCHEMBL25596169 | 0.83 | ESR1 (0.57) | BLMESR1ESR2ABATTAAR1 | |
| SCHEMBL564410 | 0.82 | ESR1 (0.67) | BLMESR1ESR2ABATTAAR1 | |
| Metyrosine SCHEMBL50398 | 0.78 | BLM (1.00) | BLMESR1ESR2ABATCA2 | |
| SCHEMBL5057766 | 0.78 | BLM (0.58) | BLMESR1ESR2ABATCA2 | |
| SCHEMBL24305563 | 0.78 | BLM (0.73) | BLMESR1ESR2ABATCA2 | |
| SCHEMBL16263572 | 0.78 | BLM (0.73) | BLMESR1ESR2ABATCA2 | |
| SCHEMBL16263574 | 0.78 | BLM (0.73) | BLMESR1ESR2ABATCA2 | |
| Acetic Acid SCHEMBL5733361 | 0.78 | BLM (0.68) | BLMESR1ESR2CA2TAAR1 | |
| Metyrosine SCHEMBL162280 | 0.78 | BLM (1.00) | BLMESR1ESR2ABATCA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230181493-A1 | BIOMARKERS RELATED TO PARKINSON'S DISEASE AND METHODS OF USING THE SAME | SENDA BIOSCIENCES INC (US) | 2023-06-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230181493-A1 | BIOMARKERS RELATED TO PARKINSON'S DISEASE AND METHODS OF USING THE SAME | COMT, SNCA, PARK7 | BLM 3756/4885ESR1 4421/4885ESR2 4494/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.